{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-052959","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.992608+00:00","generated_at":"2026-06-08T04:49:19.572067+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SANUWAVE Q3 revenue up 19% to $5.0M; net loss $23.7M on non-cash derivative charges","bullets":["Revenue $5.0M (+19% YoY); UltraMist consumables +24% to $3.1M, 62% of revenue.","Operating loss improved to $0.5M from $2.5M YoY; adjusted EBITDA loss $0.3M vs $2.2M.","Net loss $23.7M vs $1.1M YoY, driven by non-cash fair value losses on derivative liabilities.","55 UltraMist systems sold in Q3 (up from 28 in Q1 and 49 in Q2).","Gross margin 71% vs 72% YoY, stable despite growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-052959","json":"https://secwatch.observer/filing/0001140361-23-052959.json","markdown":"https://secwatch.observer/filing/0001140361-23-052959.md","text":"https://secwatch.observer/filing/0001140361-23-052959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123052959/0001140361-23-052959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123052959/ef20014647_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:49:19.572067+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ca6df34290ec92cdf53e34c1c56168b641f1b37a","claim":"SANUWAVE Health, Inc. reported the third quarter ended September 30, 2023 results: revenue $5.0 million, net income $23.7 million. Guidance reaffirmed.","evidence_excerpt":"care products, today announced its 3rd quarter 2023 results. For the three months ended September 30, 2023: ■ Revenue for the three months ended September 30, 2023 totaled $5.0 million, an increase of 19%, as compared to $4.2 million for the same period of 2022. This growth falls within the previously provided guidance range of an approximately 15 to 25%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123052959/0001140361-23-052959-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$5.0 million"},{"label":"Net income","value":"$23.7 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}